Revenue Analysis - HOLX
Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.
HOLX Corporation
Revenue by Product Line
Latest quarterly revenue breakdown by product segments
Quarterly Product Revenue
Product Revenue Details
Detailed breakdown of revenue by product line
Molecular Diagnostics
0.0% of total revenue
$329.2M
Breast Imaging
0.0% of total revenue
$280.0M
Cytology & Perinatal
0.0% of total revenue
$126.8M
Interventional Breast Solutions
0.0% of total revenue
$95.9M
Blood Screening
0.0% of total revenue
$8.4M
Historical Revenue Data
Quarterly product revenue breakdown over time (Last 6 records)
| Date | Blood Screening | Breast Imaging | Consumables | Cytology & Perinatal | Interventional Breast Solutions | Molecular Diagnostics |
|---|---|---|---|---|---|---|
| 12/27/2025 | $8.4M | $280.0M | $0 | $126.8M | $95.9M | $329.2M |
| 9/27/2025 | $0 | $19.0M | $0 | $0 | $0 | $0 |
| 6/28/2025 | $7.0M | $264.7M | $0 | $121.4M | $100.5M | $320.5M |
| 3/29/2025 | $9.1M | $271.9M | $0 | $118.5M | $84.3M | $326.0M |
| 12/28/2024 | $4.1M | $281.6M | $0 | $125.4M | $87.5M | $341.1M |
| 6/29/2024 | $0 | $0 | $623.2M | $0 | $0 | $0 |
Revenue Trend Analysis
Analysis of major growing and declining segments based on recent revenue data
Product Segments
Growing Segments
Geographic Regions
Declining Regions
Earnings Reports
Want to see how HOLX's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.
View Earnings Reports